Omnicell (Germany) Top Insiders

OC9 Stock  EUR 32.60  1.40  4.49%   
Omnicell employs about 3.6 K people. The company is managed by 17 executives with a total tenure of roughly 8400 years, averaging almost 494.0 years of service per executive, having 211.76 employees per reported executive. Examination of Omnicell's management performance can provide insight into the company performance.
Joseph Spears  Insider
Chief VP
Kathleen Nemeth  Executive
Senior Relations
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
For more detail on how to invest in Omnicell Stock please use our How to Invest in Omnicell guide.

Omnicell Management Team Effectiveness

At this time, Omnicell's Net Tangible Assets are most likely to decrease significantly in the upcoming years. The Omnicell's current Other Current Assets is estimated to increase to about 18.6 M, while Total Assets are projected to decrease to roughly 1.6 B. Omnicell's management efficiency ratios could be used to measure how well Omnicell manages its routine affairs as well as how well it operates its assets and liabilities.
The current Common Stock Shares Outstanding is estimated to decrease to about 47.3 M. The current Net Income Applicable To Common Shares is estimated to decrease to about 6.2 MOmnicell has a total of 44.88 Million outstanding shares. The majority of Omnicell outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Omnicell to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Omnicell. Please pay attention to any change in the institutional holdings of Omnicell as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Some institutional investors establish a significant position in stocks such as Omnicell in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Omnicell, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Omnicell Workforce Comparison

Omnicell is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 151,459. Omnicell holds roughly 3,600 in number of employees claiming about 2.38% of equities under Health Care industry.

Omnicell Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Omnicell Price Series Summation is a cross summation of Omnicell price series and its benchmark/peer.

Omnicell Notable Stakeholders

An Omnicell stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Omnicell often face trade-offs trying to please all of them. Omnicell's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Omnicell's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
String symbol = request.getParameter("s");

About Omnicell Management Performance

The success or failure of an entity such as Omnicell often depends on how effective the management is. Omnicell management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Omnicell management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Omnicell management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Omnicell, Inc. provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California. Omnicell operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2470 people.

Omnicell Workforce Analysis

Traditionally, organizations such as Omnicell use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Omnicell within its industry.

Omnicell Manpower Efficiency

Return on Omnicell Manpower

Revenue Per Employee309K
Revenue Per Executive65.4M
Net Income Per Employee3.5K
Net Income Per Executive737.1K
Working Capital Per Employee61.1K
Working Capital Per Executive12.9M

Complementary Tools for Omnicell Stock analysis

When running Omnicell's price analysis, check to measure Omnicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omnicell is operating at the current time. Most of Omnicell's value examination focuses on studying past and present price action to predict the probability of Omnicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omnicell's price. Additionally, you may evaluate how the addition of Omnicell to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities